{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:08Z","timestamp":1792182308631,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,8]],"date-time":"2018-07-08T00:00:00Z","timestamp":1531008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81730103"],"award-info":[{"award-number":["81730103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2017YFC0909303"],"award-info":[{"award-number":["2017YFC0909303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Key Laboratory of Construction Foundation","award":["2017B030314030"],"award-info":[{"award-number":["2017B030314030"]}]},{"name":"the Science and Technology Planning Project of Guangdong Province","award":["2017A020215147"],"award-info":[{"award-number":["2017A020215147"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00213-018-4960-2","type":"journal-article","created":{"date-parts":[[2018,7,8]],"date-time":"2018-07-08T02:28:55Z","timestamp":1531016935000},"page":"2665-2673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Polymorphisms of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients"],"prefix":"10.1007","volume":"235","author":[{"given":"Xupeng","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuncao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingsheng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liemin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,8]]},"reference":[{"key":"4960_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.taap.2017.03.022","volume":"324","author":"X Bai","year":"2017","unstructured":"Bai X, Hong W, Cai P, Chen Y, Xu C, Cao D, Yu W, Zhao Z, Huang M, Jin J (2017) Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol 324:12\u201325. \n                    https:\/\/doi.org\/10.1016\/j.taap.2017.03.022","journal-title":"Toxicol Appl Pharmacol"},{"key":"4960_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/WNL.56.2.172","volume":"56","author":"V Biton","year":"2001","unstructured":"Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS (2001) Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 56:172\u2013177","journal-title":"Neurology"},{"key":"4960_CR3","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/oby.2009.412","volume":"18","author":"S Bokor","year":"2010","unstructured":"Bokor S, Legry V, Meirhaeghe A, Ruiz JR, Mauro B, Widhalm K, Manios Y, Amouyel P, Moreno LA, Moln\u00e0r D, Dallongeville J, HELENA Study group (2010) Single-nucleotide polymorphism of CD36 locus and obesity in European adolescents. Obesity (Silver Spring) 18:1398\u20131403. \n                    https:\/\/doi.org\/10.1038\/oby.2009.412","journal-title":"Obesity (Silver Spring)"},{"key":"4960_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.psychres.2014.05.031","volume":"219","author":"EJ Brandl","year":"2014","unstructured":"Brandl EJ, Tiwari AK, Zai CC, Chowdhury NI, Lieberman JA, Meltzer HY, Kennedy JL, M\u00fcller DJ (2014) No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain. Psychiatry Res 219:255\u2013260. \n                    https:\/\/doi.org\/10.1016\/j.psychres.2014.05.031","journal-title":"Psychiatry Res"},{"key":"4960_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/0026-0495(92)90061-E","volume":"41","author":"L Breum","year":"1992","unstructured":"Breum L, Astrup A, Gram L, Andersen T, Stokholm KH, Christensen NJ, Werdelin L, Madsen J (1992) Metabolic changes during treatment with valproate in humans: implication for untoward weight gain. Metabolism 41:666\u2013670","journal-title":"Metabolism"},{"key":"4960_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jsbmb.2014.02.009","volume":"61","author":"CR Carmona-Vazquez","year":"2015","unstructured":"Carmona-Vazquez CR, Ruiz-Garcia M, Pena-Landin DM, Diaz-Garcia L, Greenawalt SR (2015) The prevalence of obesity and metabolic syndrome in paediatric patients with epilepsy treated in monotherapy with valproic acid. Rev Neurol 61:193\u2013201. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2014.02.009","journal-title":"Rev Neurol"},{"key":"4960_CR7","doi-asserted-by":"publisher","first-page":"9576503","DOI":"10.1155\/2016\/9576503","volume":"2016","author":"R Chang","year":"2016","unstructured":"Chang R, Chou MC, Hung LY, Wang ME, Hsu MC, Chiu CH (2016) Study of valproic acid-enhanced hepatocyte steatosis. Biomed Res Int 2016:9576503. \n                    https:\/\/doi.org\/10.1155\/2016\/9576503","journal-title":"Biomed Res Int"},{"key":"4960_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1017\/s0317167100021879","volume":"24","author":"CL Corman","year":"2015","unstructured":"Corman CL, Leung NM, Guberman AH (2015) Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. Can J Neurol Sci 24:240\u2013244. \n                    https:\/\/doi.org\/10.1017\/s0317167100021879","journal-title":"Can J Neurol Sci"},{"key":"4960_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1101\/gr.203201","volume":"12","author":"T Doerks","year":"2002","unstructured":"Doerks T, Copley RR, Schultz J, Ponting CP, Bork P (2002) Systematic identification of novel protein domain families associated with nuclear functions. Genome Res 12:47\u201356. \n                    https:\/\/doi.org\/10.1101\/gr.203201","journal-title":"Genome Res"},{"key":"4960_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.seizure.2006.12.009","volume":"16","author":"F El-Khatib","year":"2007","unstructured":"El-Khatib F et al (2007) Valproate, weight gain and carbohydrate craving: a gender study. Seizure 16:226\u2013232. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2006.12.009","journal-title":"Seizure"},{"key":"4960_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.seizure.2012.06.001","volume":"21","author":"J Fang","year":"2012","unstructured":"Fang J, Chen S, Tong N, Chen L, An D, Mu J, Zhou D (2012) Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate. Seizure 21:578\u2013582. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2012.06.001","journal-title":"Seizure"},{"key":"4960_CR12","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.4254\/wjh.v7.i9.1251","volume":"7","author":"E Farinelli","year":"2015","unstructured":"Farinelli E, Giampaoli D, Cenciarini A, Cercado E, Verrotti A (2015) Valproic acid and nonalcoholic fatty liver disease: a possible association? World J Hepatol 7:1251\u20131257. \n                    https:\/\/doi.org\/10.4254\/wjh.v7.i9.1251","journal-title":"World J Hepatol"},{"key":"4960_CR13","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/oby.2012.74","volume":"20","author":"VS Farook","year":"2012","unstructured":"Farook VS, Puppala S, Schneider J, Fowler SP, Chittoor G, Dyer TD, Allayee H, Cole SA, Arya R, Black MH, Curran JE, Almasy L, Buchanan TA, Jenkinson CP, Lehman DM, Watanabe RM, Blangero J, Duggirala R (2012) Metabolic syndrome is linked to chromosome 7q21 and associated with genetic variants in CD36 and GNAT3 in Mexican Americans. Obesity (Silver Spring) 20:2083\u20132092. \n                    https:\/\/doi.org\/10.1038\/oby.2012.74","journal-title":"Obesity (Silver Spring)"},{"key":"4960_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s10528-016-9743-z","volume":"54","author":"B Grygiel-Gorniak","year":"2016","unstructured":"Grygiel-Gorniak B, Kaczmarek E, Mosor M, Przyslawski J, Bogacz A (2016) Genetic background, adipocytokines, and metabolic disorders in postmenopausal overweight and obese women. Biochem Genet 54:636\u2013652. \n                    https:\/\/doi.org\/10.1007\/s10528-016-9743-z","journal-title":"Biochem Genet"},{"key":"4960_CR15","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.2337\/db06-1699","volume":"56","author":"T Hajri","year":"2007","unstructured":"Hajri T, Hall AM, Jensen DR, Pietka TA, Drover VA, Tao H, Eckel R, Abumrad NA (2007) CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabetes 56:1872\u20131880. \n                    https:\/\/doi.org\/10.2337\/db06-1699","journal-title":"Diabetes"},{"key":"4960_CR16","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/oby.2010.251","volume":"19","author":"M Heni","year":"2011","unstructured":"Heni M, M\u00fcssig K, Machicao F, Machann J, Schick F, Claussen CD, Stefan N, Fritsche A, H\u00e4ring HU, Staiger H (2011) Variants in the CD36 gene locus determine whole-body adiposity, but have no independent effect on insulin sensitivity. Obesity (Silver Spring) 19:1004\u20131009. \n                    https:\/\/doi.org\/10.1038\/oby.2010.251","journal-title":"Obesity (Silver Spring)"},{"key":"4960_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/dna.2009.0893","volume":"28","author":"H Herken","year":"2009","unstructured":"Herken H, Erdal M, Aydin N, Sengul C, Karadag F, Barlas O, Akin F (2009) The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia. DNA Cell Biol 28:515\u2013519","journal-title":"DNA Cell Biol"},{"key":"4960_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.tem.2009.04.005","volume":"20","author":"EH Jeninga","year":"2009","unstructured":"Jeninga EH, Gurnell M, Kalkhoven E (2009) Functional implications of genetic variation in human PPAR\u03b3. Trends Endocrinol Metab 20:380\u2013387. \n                    https:\/\/doi.org\/10.1016\/j.tem.2009.04.005","journal-title":"Trends Endocrinol Metab"},{"key":"4960_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.seizure.2012.05.001","volume":"21","author":"H Kanemura","year":"2012","unstructured":"Kanemura H, Sano F, Maeda Y, Sugita K, Aihara M (2012) Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy. Seizure 21:496\u2013500. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2012.05.001","journal-title":"Seizure"},{"key":"4960_CR20","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/oby.2011.374","volume":"20","author":"KL Keller","year":"2012","unstructured":"Keller KL, Liang LCH, Sakimura J, May D, van Belle C, Breen C, Driggin E, Tepper BJ, Lanzano PC, Deng L, Chung WK (2012) Common variants in the CD36 gene are associated with oral fat perception, fat preferences, and obesity in African Americans. Obesity (Silver Spring) 20:1066\u20131073. \n                    https:\/\/doi.org\/10.1038\/oby.2011.374","journal-title":"Obesity (Silver Spring)"},{"key":"4960_CR21","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/oby.2005.161","volume":"13","author":"KM Klein","year":"2005","unstructured":"Klein KM, Hamer HM, Reis J, Schmidtke J, Oertel WH, Theisen FM, Hebebrand J, Rosenow F (2005) Weight change in monozygotic twins treated with valproate. Obes Res 13:1330\u20131334","journal-title":"Obes Res"},{"key":"4960_CR22","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1172\/JCI25299","volume":"115","author":"F Laugerette","year":"2005","unstructured":"Laugerette F, Passilly-Degrace P, Patris B, Niot I, Febbraio M, Montmayeur JP, Besnard P (2005) CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J Clin Invest 115:3177\u20133184. \n                    https:\/\/doi.org\/10.1172\/JCI25299","journal-title":"J Clin Invest"},{"key":"4960_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/mp.2011.109","volume":"17","author":"TA Lett","year":"2012","unstructured":"Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Muller DJ (2012) Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 17:242\u2013266. \n                    https:\/\/doi.org\/10.1038\/mp.2011.109","journal-title":"Mol Psychiatry"},{"key":"4960_CR24","doi-asserted-by":"publisher","first-page":"pyv021","DOI":"10.1093\/ijnp\/pyv021","volume":"18","author":"H Li","year":"2015","unstructured":"Li H, Wang X, Zhou Y, Ni G, Su Q, Chen Z, Chen Z, Li J, Chen X, Hou X, Xie W, Xin S, Zhou L, Huang M (2015) Association of LEPR and ANKK1 gene polymorphisms with weight gain in epilepsy patients receiving valproic acid. Int J Neuropsychopharmacol 18:pyv021. \n                    https:\/\/doi.org\/10.1093\/ijnp\/pyv021","journal-title":"Int J Neuropsychopharmacol"},{"key":"4960_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/hmg\/ddq449","volume":"20","author":"L Love-Gregory","year":"2011","unstructured":"Love-Gregory L, Sherva R, Schappe T, Qi JS, McCrea J, Klein S, Connelly MA, Abumrad NA (2011) Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet 20:193\u2013201. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddq449","journal-title":"Hum Mol Genet"},{"key":"4960_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2188\/jea.JE20120110","volume":"23","author":"W Luo","year":"2013","unstructured":"Luo W, Guo Z, Wu M, Hao C, Hu X, Zhou Z, Zhou Z, Yao X, Zhang L, Liu J (2013) Association of peroxisome proliferator-activated receptor \u03b1\/\u03b4\/\u03b3 with obesity, and gene\u2013gene interaction, in the Chinese Han population. J Epidemiol 23:187\u2013194. \n                    https:\/\/doi.org\/10.2188\/jea.JE20120110","journal-title":"J Epidemiol"},{"key":"4960_CR27","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/hmg\/ddh233","volume":"13","author":"X Ma","year":"2004","unstructured":"Ma X, Bacci S, Mlynarski W, Gottardo L, Soccio T, Menzaghi C, Iori E, Lager RA, Shroff AR, Gervino EV, Nesto RW, Johnstone MT, Abumrad NA, Avogaro A, Trischitta V, Doria A (2004) A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 13:2197\u20132205. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddh233","journal-title":"Hum Mol Genet"},{"key":"4960_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000439285","volume":"67","author":"A Mansoori","year":"2015","unstructured":"Mansoori A, Amini M, Kolahdooz F, Seyedrezazadeh E (2015) Obesity and Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene in healthy adults: a systematic review and meta-analysis. Ann Nutr Metab 67:104\u2013118. \n                    https:\/\/doi.org\/10.1159\/000439285","journal-title":"Ann Nutr Metab"},{"key":"4960_CR29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/s0140-6736(00)04138-6","volume":"357","author":"K Miyaoka","year":"2001","unstructured":"Miyaoka K, Kuwasako T, Hirano K-i, Nozaki S, Yamashita S, Matsuzawa Y (2001) CD36 deficiency associated with insulin resistance. Lancet 357:686\u2013687. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(00)04138-6","journal-title":"Lancet"},{"key":"4960_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/ane.12473","volume":"133","author":"M Noai","year":"2016","unstructured":"Noai M, Soraoka H, Kajiwara A, Tanamachi Y, Oniki K, Nakagawa K, Ishitsu T, Saruwatari J (2016) Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain. Acta Neurol Scand 133:216\u2013223. \n                    https:\/\/doi.org\/10.1111\/ane.12473","journal-title":"Acta Neurol Scand"},{"key":"4960_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.atherosclerosis.2010.02.009","volume":"211","author":"SE Noel","year":"2010","unstructured":"Noel SE, Lai CQ, Mattei J, Parnell LD, Ordovas JM, Tucker KL (2010) Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults. Atherosclerosis 211:210\u2013215. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.02.009","journal-title":"Atherosclerosis"},{"key":"4960_CR32","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/epi.12745","volume":"55","author":"SJ Petty","year":"2014","unstructured":"Petty SJ, Kantor S, Lawrence KM, Berkovic SF, Collins M, Hill KD, Makovey J, Sambrook PN, O'Brien TJ, Wark JD (2014) Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study. Epilepsia 55:1551\u20131557. \n                    https:\/\/doi.org\/10.1111\/epi.12745","journal-title":"Epilepsia"},{"key":"4960_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/jnnp-2012303688","volume":"84","author":"WO Pickrell","year":"2013","unstructured":"Pickrell WO, Lacey AS, Thomas RH, Smith PE, Rees MI (2013) Weight change associated with antiepileptic drugs. J Neurol Neurosurg Psychiatry 84:796\u2013799. \n                    https:\/\/doi.org\/10.1136\/jnnp-2012303688","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4960_CR34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","volume":"43","author":"V Pylv\u00e4nen","year":"2002","unstructured":"Pylv\u00e4nen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isoj\u00e4rvi JI (2002) Serum insulin and leptin levels in valproate-associated obesity. Epilepsia 43:514\u2013517","journal-title":"Epilepsia"},{"key":"4960_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2119\/2006-00088.Rac","volume":"13","author":"M Rac","year":"2007","unstructured":"Rac M, Safranow K (2007) Molecular basis of human CD36 gene mutations. Mol Med 13:1. \n                    https:\/\/doi.org\/10.2119\/2006-00088.Rac","journal-title":"Mol Med"},{"key":"4960_CR36","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2337\/db06-0263","volume":"55","author":"PE Scherer","year":"2006","unstructured":"Scherer PE (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55:1537\u20131545. \n                    https:\/\/doi.org\/10.2337\/db06-0263","journal-title":"Diabetes"},{"key":"4960_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF03256433","volume":"16","author":"J Staeker","year":"2012","unstructured":"Staeker J, Leucht S, Steimer W (2012) Peroxisome proliferator-activated receptor gamma (PPARG) Pro12Ala: lack of association with weight gain in psychiatric inpatients treated with olanzapine or clozapine. Mol Diagn Ther 16:93\u201398","journal-title":"Mol Diagn Ther"},{"key":"4960_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","volume":"20","author":"X Su","year":"2009","unstructured":"Su X, Abumrad NA (2009) Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol Metab 20:72\u201377. \n                    https:\/\/doi.org\/10.1016\/j.tem.2008.11.001","journal-title":"Trends Endocrinol Metab"},{"key":"4960_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2011.00056","volume":"2","author":"HK Tiwari","year":"2011","unstructured":"Tiwari HK, Patki A, Lieberman J, Stroup TS, Allison DB, Leibel RL, Chung WK (2011) Association of allelic variation in genes mediating aspects of energy homeostasis with weight gain during administration of antipsychotic drugs (CATIE study). Front Genet 2:56. \n                    https:\/\/doi.org\/10.3389\/fgene.2011.00056","journal-title":"Front Genet"},{"key":"4960_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JCP.0b013e31827d145a","volume":"33","author":"AK Tiwari","year":"2013","unstructured":"Tiwari AK, Brandl EJ, Weber C, Likhodi O, Zai CC, Hahn MK, Lieberman JA, Meltzer HY, Kennedy JL, M\u00fcller DJ (2013) Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients. J Clin Psychopharmacol 33:11\u201317. \n                    https:\/\/doi.org\/10.1097\/JCP.0b013e31827d145a","journal-title":"J Clin Psychopharmacol"},{"key":"4960_CR41","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.4088\/JCP.v69n0909","volume":"69","author":"H Ujike","year":"2008","unstructured":"Ujike H, Nomura A, Morita Y, Morio A, Okahisa Y, Kotaka T, Kodama M, Ishihara T, Kuroda S (2008) Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. J Clin Psychiatry 69:1416\u20131422","journal-title":"J Clin Psychiatry"},{"key":"4960_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/088307380201700405","volume":"17","author":"A Verrotti","year":"2002","unstructured":"Verrotti A, Basciani F, De Simone M, Trotta D, Morgese G, Chiarelli F (2002) Insulin resistance in epileptic girls who gain weight after therapy with valproic acid. J Child Neurol 17:265\u2013268","journal-title":"J Child Neurol"},{"key":"4960_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000197868","volume":"71","author":"A Verrotti","year":"2009","unstructured":"Verrotti A, la Torre R, Trotta D, Mohn A, Chiarelli F (2009) Valproate-induced insulin resistance and obesity in children. Horm Res 71:125\u2013131. \n                    https:\/\/doi.org\/10.1159\/000197868","journal-title":"Horm Res"},{"key":"4960_CR44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/417292a","volume":"417","author":"RS Williams","year":"2002","unstructured":"Williams RS, Cheng L, Mudge AW, Harwood AJ (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417:292\u2013295","journal-title":"Nature"},{"key":"4960_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.08.027","volume":"127","author":"Y Yamamoto","year":"2016","unstructured":"Yamamoto Y, Terada K, Takahashi Y, Imai K, Kagawa Y, Inoue Y (2016) Influence of antiepileptic drugs on serum lipid levels in adult epilepsy patients. Epilepsy Res 127:101\u2013106. \n                    https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.08.027","journal-title":"Epilepsy Res"},{"key":"4960_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","volume":"134","author":"J Zhou","year":"2008","unstructured":"Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, Lee JH, Khadem S, Ren S, Li S, Silverstein RL, Xie W (2008) Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPAR\u03b3 in promoting steatosis. Gastroenterology 134:556\u2013567. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2007.11.037","journal-title":"Gastroenterology"},{"key":"4960_CR47","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1111\/bph.13320","volume":"172","author":"AM Zuckermann","year":"2015","unstructured":"Zuckermann AM, La Ragione RM, Baines DL, Williams RS (2015) Valproic acid protects against haemorrhagic shock-induced signalling changes via PPAR\u03b3 activation in an in vitro model. Br J Pharmacol 172:5306\u20135317. \n                    https:\/\/doi.org\/10.1111\/bph.13320","journal-title":"Br J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-4960-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T19:06:32Z","timestamp":1562526392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-4960-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,8]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4960"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-4960-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,8]]},"assertion":[{"value":"25 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Human Investigation Ethics Committee of the School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China (Clinicaltrials.gov Identifier No. NCT01172626). It was conducted in accordance with the Declaration of Helsinki and was consistent with applicable guidelines of good clinical practice.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}